It was reported that the genetic or functional inactivation of p53 seemed the most common abnormality in BC-CML and that the TP53 gene was mutated in 25–30% of patients with MBP-CML [23]. The gene discussed is MBP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.